HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Glenmark to divest select brands to Dr Reddy’s in Russia, Ukraine, Kazakhstan and Uzbekistan
Nov-30-2020

Glenmark Pharmaceuticals has entered into a definitive agreement with Dr. Reddy’s Laboratories to divest - subject to completion of certain precedent actions and closing activities - its brand Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along with rights to the trademarks, dossiers and patents for the territories mentioned.

The divested brand and its extensions represent two types of products, i.e Mometasone mono product and combination of Mometasone with Azelastine, and are indicated for the treatment of Seasonal and Perennial Allergic Rhinitis.

Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

  RELATED NEWS >>